Provided by Tiger Trade Technology Pte. Ltd.

iShares U.S. Pharmaceuticals ETF

101.53
-0.7400-0.72%
Pre-market: 101.530.00000.00%07:29 EDT
Volume:74.09K
Turnover:7.53M
Market Cap:1.66B
PE:9.46
High:102.23
Open:102.02
Low:101.24
Close:102.27
52wk High:108.66
52wk Low:69.02
Shares:16.35M
Float Shares:16.35M
Volume Ratio:0.45
T/O Rate:0.45%
Dividend:1.43
Dividend Rate:1.41%
EPS(TTM):10.74
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

LIVE Markets-Big Beauty Faces Growing Threat from AI, Smaller Rivals

Reuters
·
13 mins ago

Sichuan Biokin Pharmaceutical Says Unit Received $250 Mln Milestone Payment from Bristol-Myers Squibb for Iza-Bren Agreement

THOMSON REUTERS
·
17 mins ago

Oura - Eli Lilly Interested in Purchasing up to $100 Mln; Dragoneer up to $300 Mln in IPO - SEC Filing

THOMSON REUTERS
·
37 mins ago

Japan Health Ministry Approves Merck’s Keytruda QLEX for Subcutaneous Use Across Keytruda Indications

Reuters
·
47 mins ago

Merck’s Keytruda Qlex™ (Pembrolizumab and Berahyaluronidase Alfa-Pmph) Approved in Japan for Subcutaneous Administration for All Keytruda® (Pembrolizumab) Indications Approved in Japan

THOMSON REUTERS
·
48 mins ago

Novo Says Its Next-Gen Obesity Drug Tops Lilly Rival in Late-Stage Study

Reuters
·
49 mins ago

Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK), Envista Holdings (NVST) and Ultragenyx Pharmaceutical (RARE)

TIPRANKS
·
10 hours ago

Eli Lilly, Novo sued over risk of sudden vision loss, WSJ reports

TIPRANKS
·
Yesterday

Retension Pharmaceuticals, TRex Bio File for US IPO as Biotech Momentum Continues

Reuters
·
Sep 19

3 ‘Strong Buy’ Dividend Aristocrat Stocks to Generate Steady Cash

TIPRANKS
·
Sep 19

Sector Update: Healthcare

MT Newswires Live
·
Sep 19

Eli Lilly reports full FDA approval of Inluriyo combo for certain breast cancers

TIPRANKS
·
Sep 19

US FDA Approves Lilly Inluriyo-Verzenio Combo for ESR1-Mutated Metastatic Breast Cancer

Reuters
·
Sep 19

U.S. FDA Approves Inluriyo (Imlunestrant) in Combination with Verzenio (Abemaciclib) for Adults with Er+, Her2-, Esr1-Mutated Advanced or Metastatic Breast Cancer

THOMSON REUTERS
·
Sep 19

Eli Lilly - Inluriyo with Verzenio NOW Available in the United States

THOMSON REUTERS
·
Sep 19

Bloomsbury Publishing (BMY) Gets a Buy from Berenberg Bank

TIPRANKS
·
Sep 18

Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), BioMarin Pharmaceutical (BMRN) and Axsome Therapeutics (AXSM)

TIPRANKS
·
Sep 18

Bristol Myers Squibb to Report Q3 Results, Host Earnings Call

Reuters
·
Sep 18

Bristol Myers Squibb to Report Results for Third Quarter 2026 on October 29, 2026

THOMSON REUTERS
·
Sep 18

Merck Says EU CHMP Backs Keytruda-Padcev Perioperative Use in Resectable Muscle-Invasive Bladder Cancer

Reuters
·
Sep 18